Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 7/20 | 0.61 |
| ▸ | CTRB1 | P17538 | 4/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6635647 | 0.93 | ELANE (0.60) | ELANECTRB1GAABACE1 | |
| SCHEMBL6639790 | 0.92 | CTRB1 (0.59) | ELANECTRB1LMNAALDH1A1CYP3A4 | |
| SCHEMBL6635623 | 0.89 | CTRB1 (0.60) | ELANECTRB1ALDH1A1MEN1KMT2A | |
| SCHEMBL6637660 | 0.86 | ELANE (0.58) | ELANECTRB1MEN1KMT2ACYP17A1 | |
| SCHEMBL6635091 | 0.85 | CTRB1 (0.54) | ELANECTRB1GAABACE1LMNA | |
| SCHEMBL6636103 | 0.85 | CTRB1 (0.57) | ELANECTRB1LMNAALDH1A1CYP3A4 | |
| SCHEMBL6638769 | 0.84 | ELANE (0.55) | ELANECTRB1CYP3A4KMT2ACYP17A1 | |
| SCHEMBL6638457 | 0.83 | ELANE (0.49) | ELANECTRB1BACE1CYP3A4KMT2A | |
| SCHEMBL6636032 | 0.82 | CTRB1 (0.59) | ELANECTRB1ALDH1A1MEN1KMT2A | |
| SCHEMBL6638394 | 0.81 | CTRB1 (0.56) | ELANECTRB1GAALMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |